✦ LIBER ✦

Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Albiglutide, a Long-Acting Glucagon-Like Peptide-1 Mimetic, in Patients with Type 2 Diabetes

✍ Scribed by Matthews, Jessica E.; Stewart, Murray W.; De Boever, Erika H.; Dobbins, Robert L.; Hodge, Rebecca J.; Walker, Susan E.; Holland, M. Claire; Bush, Mark A.

Book ID: 120835073
Publisher: Endocrine Society
Year: 2008
Tongue: English
Weight: 156 KB
Volume: 93
Category: Article
ISSN: 0021-972X
DOI: 10.1210/jc.2008-1518

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, tolerability, pharmacodynamics a

Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects

✍ M. A. Bush; J. E. Matthews; E. H. De Boever; R. L. Dobbins; R. J. Hodge; S. E. W 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Safety, tolerability, pharmacokinetics a

Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus

✍ Seino, Yutaka; Nakajima, Hiromu; Miyahara, Hajime; Kurita, Takashi; Bush, Mark A 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 230 KB

A 5-week study of the pharmacokinetics a

A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes

✍ P. Barrington; J. Y. Chien; H. D. H. Showalter; K. Schneck; S. Cui; F. Tibaldi; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

Safety, Tolerability, Pharmacokinetics,

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus

✍ Tim Heise, Leo Seman, Sreeraj Macha, Peter Jones, Alexandra Marquart… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 608 KB

Effects of the long-acting human glucago

Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus

✍ Pijun Yan; Ling Li; Mengliu Yang; Dongfang Liu; Hua Liu; Guenther Boden; Gangyi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Efficacy and Safety of Long-Acting Gluca

Efficacy and Safety of Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Compared with Exenatide Twice Daily and Sitagliptin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

✍ Pinelli, N. R.; Hurren, K. M. 📂 Article 📅 2011 🏛 Harvey Whitney Books Company 🌐 English ⚖ 278 KB